Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitorXingyue He, Sai Murali Krishna Pulukuri, Eric S. Lightcap et al.|Nature Chemical Biology|2017Cited by 228
Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of CancerSteven Langston, Xiaofeng Yang, Scott Freeze et al.|Journal of Medicinal Chemistry|2021Cited by 205
Design and Optimization of Potent and Orally Bioavailable Tetrahydronaphthalene Raf InhibitorsAlexandra E. Gould, Katherine Galvin, Tricia J. Vos et al.|Journal of Medicinal Chemistry|2011Cited by 33
Discovery and optimization of pyrazoline compounds as B-Raf inhibitorsMatthew O. Duffey, Qin Zhang, Johnny Yang et al.|Bioorganic & Medicinal Chemistry Letters|2010Cited by 15